Ross, P., Cid, T., Fernández Quintero, M., Loeffler, J., Fatima, H., Leaman, D. P., Matthias, J., Spencer, K., Zwick, M. B., Henderson, S. C., Ward, A. B., Mace, E. M., & Murin, C. D. (2025). CD16a pairs form the basal molecular subunit for the NK-cell ADCC lytic synapse. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf077

Liu, Y., Brown, C. M., Erramilli, S., Su, Y.-C., Guu, S.-Y., Tseng, P.-S., Wang, Y.-J., Duong, N. H., Tokarz, P., Kloss, B., Han, C.-R., Chen, H.-Y., Rodrigues, J., Khoo, K.-H., Archer, M., Kossiakoff, A. A., Lowary, T. L., Stansfeld, P. J., Nygaard, R., & Mancia, F. (2025). Structural insights into terminal arabinosylation of mycobacterial cell wall arabinan. Nature Communications, 16(1). https://doi.org/10.1038/s41467-025-58196-5

Liu, Y., Brown, C. M., Borges, N., Nobre, R. N., Erramilli, S., Belcher Dufrisne, M., Kloss, B., Giacometti, S., Esteves, A. M., Timóteo, C. G., Tokarz, P., Cater, R. J., Lowary, T. L., Morita, Y. S., Kossiakoff, A. A., Santos, H., Stansfeld, P. J., Nygaard, R., & Mancia, F. (2025). Mechanistic studies of mycobacterial glycolipid biosynthesis by the mannosyltransferase PimE. Nature Communications, 16(1). https://doi.org/10.1038/s41467-025-57843-1

Aguiar, T., Mashiko, S., Asam, K., Roy, P., Wang, S., Frank, K., Dietzel, M., Schahadat, L. G. Z., Ausmeier, M., Hertel, A., Duan, Z. R. S., Aouizerat, B., Genkinger, J. M., Remotti, H., & Zorn, E. (2025). Development of high-titer class-switched antibody responses to phosphorylated amino acids is prevalent in pancreatic ductal adenocarcinoma. Frontiers in Immunology, 16. https://doi.org/10.3389/fimmu.2025.1501943

Loffredo, L. F., Kustagi, A., Ringham, O. R., Li, F., de los Santos-Alexis, K., Saqi, A., & Arpaia, N. (2025). Heparan sulfate regulates amphiregulin programming of tissue reparative lung mesenchymal cells during influenza A virus infection in mice. Nature Communications, 16(1). https://doi.org/10.1038/s41467-025-57362-z

Sharma, M. R., Johnson, M. L., Puzanov, I., Sznol, M., Mckean, M., Gainor, J. F., Spira, A., Henick, B., Tolcher, A. W., Chen, C. T., El-Khoueiry, A., Broderick, J., Peng, L., Che, J., Cao, L., Wilson, D., Lathers, D., Horak, C., Feltquate, D., & Luke, J. J. (2024). 758 GLIMMER-01: phase 1/2 trial of a first-in-class bi-sialidase (E-602) in combination with cemiplimab in patients with PD-(L)1-resistant solid tumors. Regular and Young Investigator Award Abstracts, A862–A862. https://doi.org/10.1136/jitc-2024-sitc2024.0758

Yaron-Barir, T. M., Joughin, B. A., Huntsman, E. M., Kerelsky, A., Cizin, D. M., Cohen, B. M., Regev, A., Song, J., Vasan, N., Lin, T.-Y., Orozco, J. M., Schoenherr, C., Sagum, C., Bedford, M. T., Wynn, R. M., Tso, S.-C., Chuang, D. T., Li, L., Li, S. S.-C., … Johnson, J. L. (2024). The intrinsic substrate specificity of the human tyrosine kinome. Nature, 629(8014), 1174–1181. https://doi.org/10.1038/s41586-024-07407-y

Benavente, M. C. R., Hakeem, Z. A., Davis, A. R., Murray, N. B., Azadi, P., Mace, E. M., & Barb, A. W. (2024). Distinct CD16a features on human NK cells observed by flow cytometry correlate with increased ADCC. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-58541-6

Berger, S., Mito, Y., & Mehta, L. (2024). P200: A novel 13q31.3q32.3 deletion identified on follow up of an inconclusive prenatal cell-Free DNA screening for trisomy 13. Genetics in Medicine Open, 2, 101097. https://doi.org/10.1016/j.gimo.2024.101097

Sharma, M., Lathers, D., Johnson, M., Luke, J., Puzanov, I., Curti, B., Chen, C., El-Khoueiry, A., Henick, B., Callahan, M., Sznol, M., Patel, S., Wilson, D., Ricker, M., Cao, L., Jayaraman, P., Che, J., Peng, L., Feltquate, D., … Tolcher, A. (2022). 772 A phase 1/2 dose escalation/expansion study evaluating the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of E-602, a bi-sialidase fusion protein, in advanced cancer (GLIMMER-01). Regular and Young Investigator Award Abstracts, A803–A803. https://doi.org/10.1136/jitc-2022-sitc2022.0772

Qiu, A., Miller, A., Zotti, F. D., Santhanakrishnan, M., Hendrickson, J. E., Tredicine, M., Stowell, S. R., Luckey, C. J., Zimring, J. C., & Hudson, K. E. (2022). FcγRIV is required for IgG2c mediated enhancement of RBC alloimmunization. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.972723

Hamid, O., Sato, T., Davar, D., Callahan, M. K., Thistlethwaite, F., Aljumaily, R., Johnson, M. L., Arkenau, H.-T., Ileana Dumbrava, E. E., Izar, B., Chen, H. A., Marshall, S., Yuan, Y., Deo, M., Stanhope, S., Collins, L., Mundy, R., Abdullah, S. E., & Lopez, J. S. (2022). 728O Results from phase I dose escalation of IMC-F106C, the first PRAME × CD3 ImmTAC bispecific protein in solid tumors. Annals of Oncology, 33, S875. https://doi.org/10.1016/j.annonc.2022.07.854

Liaqat, K., Hussain, S., Acharya, A., Nasir, A., Bharadwaj, T., Ansar, M., Basit, S., Schrauwen, I., Ahmad, W., & Leal, S. M. (2022). Phenotype Expansion for Atypical Gaucher Disease Due to Homozygous Missense PSAP Variant in a Large Consanguineous Pakistani Family. Genes, 13(4), 662. https://doi.org/10.3390/genes13040662

Wontakal, S. N., Britto, M., Zhang, H., Han, Y., Gao, C., Tannenbaum, S., Durham, B. H., Lee, M. T., An, X., & Mishima, M. (2022). RACGAP1 variants in a sporadic case of CDA III implicate the dysfunction of centralspindlin as the basis of the disease. Blood, 139(9), 1413–1418. https://doi.org/10.1182/blood.2021012334

Alselehdar, S. K., Chakraborty, M., Chowdhury, S., Alcalay, R. N., Surface, M., & Ledeen, R. (2021). Subnormal GM1 in PBMCs: Promise for Early Diagnosis of Parkinson’s Disease? International Journal of Molecular Sciences, 22(21), 11522. https://doi.org/10.3390/ijms222111522